148 related articles for article (PubMed ID: 18814144)
1. Modulation of mouse RANKL gene expression by Runx2 and vitamin D3.
Kitazawa R; Mori K; Yamaguchi A; Kondo T; Kitazawa S
J Cell Biochem; 2008 Dec; 105(5):1289-97. PubMed ID: 18814144
[TBL] [Abstract][Full Text] [Related]
2. Modulation of mouse RANKL gene expression by Runx2 and PKA pathway.
Mori K; Kitazawa R; Kondo T; Maeda S; Yamaguchi A; Kitazawa S
J Cell Biochem; 2006 Aug; 98(6):1629-44. PubMed ID: 16598781
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D3 supports osteoclastogenesis via functional vitamin D response element of human RANKL gene promoter.
Kitazawa S; Kajimoto K; Kondo T; Kitazawa R
J Cell Biochem; 2003 Jul; 89(4):771-7. PubMed ID: 12858342
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D(3) augments osteoclastogenesis via vitamin D-responsive element of mouse RANKL gene promoter.
Kitazawa R; Kitazawa S
Biochem Biophys Res Commun; 2002 Jan; 290(2):650-5. PubMed ID: 11785948
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic control of mouse receptor activator of NF-kappa B ligand gene expression.
Kitazawa S; Kitazawa R
Biochem Biophys Res Commun; 2002 Apr; 293(1):126-31. PubMed ID: 12054573
[TBL] [Abstract][Full Text] [Related]
6. Novel vitamin D3 analogs, 1alpha, 25(OH)2D(3)-26, 23-lactam (DLAMs), antagonize bone resorption via suppressing RANKL expression in osteoblasts.
Inada M; Tsukamoto K; Hirata M; Takita M; Nagasawa K; Miyaura C
Biochem Biophys Res Commun; 2008 Aug; 372(3):434-9. PubMed ID: 18489902
[TBL] [Abstract][Full Text] [Related]
7. Methylation status of a single CpG locus 3 bases upstream of TATA-box of receptor activator of nuclear factor-kappaB ligand (RANKL) gene promoter modulates cell- and tissue-specific RANKL expression and osteoclastogenesis.
Kitazawa R; Kitazawa S
Mol Endocrinol; 2007 Jan; 21(1):148-58. PubMed ID: 17008384
[TBL] [Abstract][Full Text] [Related]
8. BMP-2 promotes differentiation of osteoblasts and chondroblasts in Runx2-deficient cell lines.
Liu T; Gao Y; Sakamoto K; Minamizato T; Furukawa K; Tsukazaki T; Shibata Y; Bessho K; Komori T; Yamaguchi A
J Cell Physiol; 2007 Jun; 211(3):728-35. PubMed ID: 17226753
[TBL] [Abstract][Full Text] [Related]
9. 1,25-(OH)2-vitamin D3 suppresses the bone-related Runx2/Cbfa1 gene promoter.
Drissi H; Pouliot A; Koolloos C; Stein JL; Lian JB; Stein GS; van Wijnen AJ
Exp Cell Res; 2002 Apr; 274(2):323-33. PubMed ID: 11900492
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional induction of matrix metalloproteinase-13 (collagenase-3) by 1alpha,25-dihydroxyvitamin D3 in mouse osteoblastic MC3T3-E1 cells.
Uchida M; Shima M; Chikazu D; Fujieda A; Obara K; Suzuki H; Nagai Y; Yamato H; Kawaguchi H
J Bone Miner Res; 2001 Feb; 16(2):221-30. PubMed ID: 11204422
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the Runx2 promoter in osseous and non-osseous cells and identification of HIF2A as a potent transcription activator.
Tamiya H; Ikeda T; Jeong JH; Saito T; Yano F; Jung YK; Ohba S; Kawaguchi H; Chung UI; Choi JY
Gene; 2008 Jun; 416(1-2):53-60. PubMed ID: 18442887
[TBL] [Abstract][Full Text] [Related]
12. Prolactin decreases expression of Runx2, osteoprotegerin, and RANKL in primary osteoblasts derived from tibiae of adult female rats.
Charoenphandhu N; Teerapornpuntakit J; Methawasin M; Wongdee K; Thongchote K; Krishnamra N
Can J Physiol Pharmacol; 2008 May; 86(5):240-8. PubMed ID: 18432284
[TBL] [Abstract][Full Text] [Related]
13. Dexamethasone promotes osteoclastogenesis by inhibiting osteoprotegerin through multiple levels.
Kondo T; Kitazawa R; Yamaguchi A; Kitazawa S
J Cell Biochem; 2008 Jan; 103(1):335-45. PubMed ID: 17516544
[TBL] [Abstract][Full Text] [Related]
14. Identification of NFAT binding sites that mediate stimulation of cathepsin K promoter activity by RANK ligand.
Balkan W; Martinez AF; Fernandez I; Rodriguez MA; Pang M; Troen BR
Gene; 2009 Oct; 446(2):90-8. PubMed ID: 19563866
[TBL] [Abstract][Full Text] [Related]
15. Response to mechanical strain in an immortalized pre-osteoblast cell is dependent on ERK1/2.
Fan X; Rahnert JA; Murphy TC; Nanes MS; Greenfield EM; Rubin J
J Cell Physiol; 2006 May; 207(2):454-60. PubMed ID: 16419041
[TBL] [Abstract][Full Text] [Related]
16. Bone loss induced by Runx2 over-expression in mice is blunted by osteoblastic over-expression of TIMP-1.
Schiltz C; Prouillet C; Marty C; Merciris D; Collet C; de Vernejoul MC; Geoffroy V
J Cell Physiol; 2010 Jan; 222(1):219-29. PubMed ID: 19780057
[TBL] [Abstract][Full Text] [Related]
17. Deletion of the Distal Tnfsf11 RL-D2 Enhancer That Contributes to PTH-Mediated RANKL Expression in Osteoblast Lineage Cells Results in a High Bone Mass Phenotype in Mice.
Onal M; St John HC; Danielson AL; Pike JW
J Bone Miner Res; 2016 Feb; 31(2):416-29. PubMed ID: 26332516
[TBL] [Abstract][Full Text] [Related]
18. Regulation of RANKL promoter activity is associated with histone remodeling in murine bone stromal cells.
Fan X; Roy EM; Murphy TC; Nanes MS; Kim S; Pike JW; Rubin J
J Cell Biochem; 2004 Nov; 93(4):807-18. PubMed ID: 15389882
[TBL] [Abstract][Full Text] [Related]
19. RUNX2 Mutation Impairs 1α,25-Dihydroxyvitamin D3 mediated Osteoclastogenesis in Dental Follicle Cells.
Wang XZ; Sun XY; Zhang CY; Yang X; Yan WJ; Ge LH; Zheng SG
Sci Rep; 2016 Apr; 6():24225. PubMed ID: 27068678
[TBL] [Abstract][Full Text] [Related]
20. Human estrogen receptor alpha gene is a target of Runx2 transcription factor in osteoblasts.
Lambertini E; Penolazzi L; Tavanti E; Schincaglia GP; Zennaro M; Gambari R; Piva R
Exp Cell Res; 2007 May; 313(8):1548-60. PubMed ID: 17350616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]